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Ebola virus (EBOV) belongs to the Filoviridae family of negative-sense RNA viruses. Since its
identification in 1976, sporadic outbreaks have occurred in Central Africa. The 2014 outbreak
in West Africa provides evidence that EBOV is emerging into new geographic regions. While
previous outbreaks have been confined to small areas, the most recent outbreak is atypically
widespread with over 25,000 people infected. Evidence from the limited-sequence studies that
have been published suggests that the outbreak resulted from a single reservoir-to-human
transmission event and subsequent human-to-human spread [1]. As neither an EBOV vaccine
nor antivirals are currently available, this outbreak highlights the critical need for the develop-
ment of effective vaccines and therapeutics.
Infection is initiated by virions entering dendritic cells, macrophages, and, perhaps, hepato-
cytes [2]. Virus replication in these cells is thought to be critical for initiation of systemic infec-
tion, leading to virus spread to new sites with infection of additional cell populations. Thus, a
better understanding of virus entry will not only provide insight into both host cell and virus
biology, but also elucidate therapeutic targets. Here we provide a brief overview of the current
understanding of EBOV entry and identify important questions that remain unanswered in
the field.
Filovirus Particles
The uniquely shaped filamentous particles made by filoviruses are surrounded by an envelope
acquired during virion budding from the plasma membrane (Fig 1). Recent studies provide evi-
dence that the outer leaflet of the viral envelope contains phosphatidylserine (PtdSer), which
serves as an important attachment factor during entry [3,4]. Inside the envelope, the viral ma-
trix proteins VP40 and VP24 line the inner leaflet and provide structural support. Surrounded
by this protective layer of lipids and matrix proteins, the RNA genome is associated with sever-
al viral proteins, forming the ribonucleoprotein (RNP) complex. A single viral glycoprotein
(GP), encoded by the virus, embeds in the viral envelope and is required for virion/cellular
membrane fusion. The mature GP is composed of two subunits, GP1 (~140 kDa) and GP2
(~26 kDa), that heterodimerize through disulfide bonds and associate to form trimers (Fig 2).
The crystal structure of the EBOV GP reveals that this trimer forms a chalice-like shape, with
the GP2 forming the base and GP1 forming the cup [5]. Surrounding and protecting this chal-
ice is the N-glycan-containing cap region and a heavily N- and O-glycosylated mucin-like do-
main (MLD) of GP1. Glycans on these regions are important for shielding the GP from
neutralizing antibodies [6].
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Adherence and Internalization
The cell surface interactions of filoviruses differ from other characterized enveloped virus/cell
surface receptor interactions in that amino acid residues of EBOV GP are not thought to inter-
act with a cell surface receptor. Instead, these viruses bind to target cells through two types of
relatively non-specific receptors: C-type lectins (CLECs) that interact with glycans on EBOV
GP and PtdSer receptors that interact with the viral envelope PtdSer (Fig 3A). CLECs (LSEC-
Tin, DC-SIGN [dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integ-
rin], L-SIGN [liver/lymph node-specific ICAM-3 grabbing nonintegrin], mannose-binding
lectin, and hMGL [human macrophage galactose- and N-acetylgalactosamine-specific C-type
lectin]) bind N- and O-linked glycans on EBOV GP, leading to enhanced EBOV entry, al-
though the details of how these interactions lead to virion internalization have yet to be studied.
Cells lacking CLEC expression remain permissive for EBOV infection, providing evidence that
CLEC-independent uptake mechanisms also occur. More recently appreciated is the role of cel-
lular receptors that bind to PtdSer present in the viral envelope (reviewed in [7]). These PtdSer
receptors include members of the T-cell immunoglobulin and mucin domain (TIM) family,
TIM-1 and TIM-4, and protein complexes composed of Gas6 or Protein S and the TAM family
of receptor tyrosine kinases, Tyro3, Axl, and Mer. Given that PtdSer is believed to be present
Fig 1. Ebola Virus Particle. An EBOV particle is shown with key viral proteins highlighted, including: the viral glycoprotein, matrix proteins (VP40, VP24),
and viral ribonucleoprotein complex (RNA-dependent RNA polymerase, VP30, VP35, nucleoprotein, and RNA).
doi:10.1371/journal.ppat.1004731.g001
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on the surface of most, if not all, viral envelopes, it is not surprising that virion entry via virion-
associated PtdSer/host PtdSer receptors interactions is not limited to filoviruses, but has recent-
ly been observed to mediate entry of a variety of enveloped viruses including flaviviruses,
alphaviruses, and baculoviruses. While evidence suggests that TIM-1 can mediate virion inter-
nalization without cytoplasmic tail signaling [3,8], mechanistic details of TIM-1-dependent vi-
rion uptake are not currently established. In contrast, virus/TAM family receptor interactions
trigger a signaling cascade that dampens the cell’s innate immune response, increasing the tar-
get cell permissivity [9]. Interestingly, enveloped virus interactions with CLECs may also
immunomodulate immune responses of virus-infected DCs [10]. The relative importance of
these various cell surface interactions for EBOV entry and pathogenesis, regardless of whether
they bind GP glycans or envelope lipids, remains to be characterized in vivo.
Ebola virions are thought to be internalized primarily through macropinocytosis (Fig 3B),
although other routes of uptake have also been reported [11–14]. The mechanism triggering
EBOV uptake remains unknown; however, we and others have shown that PtdSer receptor-de-
pendent internalization of viral particles does not require the presence of a viral glycoprotein
Fig 2. Structure of the EBOV glycoprotein (GP). (Top) Each monomer of GP consists of a GP1 and GP2
heterodimer associated via a disulfide bond. GP1 contains the receptor binding domain (RBD), protected by
a glycan cap and a mucin like domain (MLD) at the apex of the structure. The RBD interacts with the
endosomal receptor Niemann-Pick C1 (NPC1) upon proteolytic processing of GP1 that removes the glycan
cap and MLD. The fusion loop, which imbeds in the target membrane during fusion, is part of the GP2
monomer, but remains hidden in the mature pre-fusion GP trimer. (Bottom)The GP trimer consists of three
GP1/2 heterodimers (shown in different shades) that associate through several GP1/GP2 and GP2/
GP2 interactions.
doi:10.1371/journal.ppat.1004731.g002
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on the particle [4,15]. Further, virion binding to CLECs or PtdSer receptors has not been
shown to directly trigger macropinocytosis, so elucidation of the mechanism eliciting filovirion
macropinocytosis is still needed. Another piece of the virion internalization puzzle that re-
mains unsolved is how vesicular stomatitis virus (VSV) pseudovirions that are pseudotyped
with EBOV GP internalize via macropinocytosis, whereas VSV containing its native G glyco-
protein enters cells through clathrin-coated pits [16,17]. One possible explanation for this ap-
parent disparity is that VSV displaying its native G glycoprotein interacts directly with its
recently identified cellular receptor, the ubiquitous LDL receptor [18]. In contrast, the EBOV
GP on pseudotyped VSV does not strongly interact with any cell surface receptors and EBOV
Fig 3. Steps of Ebola Virus Entry. (A) Cell surface receptors bind EBOV particles through interactions with either virion-associated phosphatidylserine or
viral glycoprotein glycans. (B) Virus is internalized through ruffling of the plasmamembrane and macropinocytosis. (C) During trafficking through endosomes,
the EBOV glycoprotein is cleaved by proteases that remove the mucin-like domain (MLD) and glycan cap, exposing the receptor binding domain (RBD).
Shown is a stepwise removal of those sequences, although in the cell these cleavage events may occur concurrently. (D) The RBD interacts with NPC1 in
the late endosome/lysosome. (E) Binding of the NPC1 C-loop by the glycoprotein is followed by one or more triggers that release the fusion loop, allowing for
its insertion into the target membrane. Subsequent transition of the EBOVGP into a six helix bundle results in the host and viral membranes being brought
together, leading to fusion. (F) Release of the viral nucleoprotein into the cytoplasm prior to the initiation of virus replication.
doi:10.1371/journal.ppat.1004731.g003
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instead utilizes less specific, lower affinity internalization mechanisms, such as PtdSer/PtdSer
receptor and/or glycan/lectin interactions. Potentially, it is through these latter interactions
that EBOV macropinocytosis occurs.
Processing and Trafficking
Ebola virions internalize into early endosomes and subsequently traffic to the late endosome/
lysosome in a Rab5 and Rab7 GTPase-dependent manner [19]. Within the endosome, low-
pH-dependent proteases remove the heavily glycosylated MLD and glycan cap from GP1, re-
sulting in a 17- to 19-kDa protein (Fig 3C) [20,21]. Cathepsins L and B were initially identified
as the proteases essential for EBOV GP processing and their cleavage sites within EBOV GP
have been mapped [22,23]. However, bacterial thermolysin and proteases present in Vero E6
cells and mouse embryonic fibroblasts can effectively substitute for these cathepsins [20,24].
Proteolytic processing of GP is necessary for exposure of the GP1 receptor binding domain
(RBD), but is insufficient to initiate virus fusion at 37°C [5,25]. However, at higher tempera-
tures under low pH and/or mild reducing conditions, the 19-kDa form of the GP binds to lipo-
somes, suggesting that this version of the trimer is in a fusion-ready state [26].
Endolysosomal Receptor Binding
The exposed RBD of the proteolytically primed GP1 binds to the late endosomal/lysosomal
protein NPC1 (Fig 3D) [27,28]. This novel endosomal interaction is essential for subsequent fi-
lovirus/cell membrane fusion. Whether processed GP interaction with NPC1 directly triggers
fusion or subsequent steps are needed remains unclear. Several groups have shown that addi-
tional endosomal proteolysis and/or reduction are required for EBOV fusion, but the chronolo-
gy and endosomal location of these events have yet to be clarified [20,21,26,29].
EBOV membrane fusion events are thought to be similar to those described for other viral
glycoproteins [30]. A hydrophobic fusion loop of GP2, normally buried beneath a neighboring
GP1 monomer [5], becomes exposed by the fusion trigger (Fig 2 and Fig 3E). Low pH condi-
tions are necessary for conformational changes within the fusion loop that promote fusion
[31]. In the form of a fist-like structure, hydrophobic GP2 residues present at the tip of the fu-
sion loop insert into the target membrane [32]. The GP2 trimer unwinds and refolds into a six-
helix bundle in which the fusion loop and GP transmembrane domain meet [33]. The resulting
fusion pore allows for release of the RNP into the cytoplasm and the start of virus replication
(Fig 3F).
Lessons from EBOV Entry Studies and Outstanding Questions
To date, investigation of EBOV entry has led to three paradigm-shifting insights. First, the dis-
covery of PtdSer receptor-mediated entry for not only filoviruses but also for a variety of other
enveloped viruses has helped to mechanistically elucidate the broad tropism of some enveloped
viruses. Second, recognition of the low pH-dependent endosomal proteolytic processing of
EBOV GP identified a novel low-pH-dependent mechanism that has now been shown to be re-
quired for a number of enveloped viruses. Third, identifying an endosomal receptor for filovi-
ruses altered the understanding of potential locations of virus/receptor interactions. While this
latter observation was initially made for filoviruses, recent studies have shown that lysosomal-
associated membrane protein 1 (LAMP1) is a lysosomal receptor for Lassa virus, suggesting
this endosomal mechanism of fusion control may be broader than previously appreciated [34].
Despite the progress over the past five years in understanding EBOV entry, many critical
questions remain unanswered. For instance, how does PtdSer become enriched on the outer
leaflet of enveloped virus membranes? Do virion interactions with CLECs, TIM proteins, or
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TAM/Gas6 complexes mediate direct internalization of virions into endosomes? If TIM pro-
teins do directly mediate virus internalization, mechanistically, how is this accomplished since
some TIM molecules are not thought to signal? Alternatively, do these receptors solely accu-
mulate virions on the surface of cells? If so, is there a yet unidentified cell-surface receptor that
is required for EBOV internalization? If PtdSer receptors do directly mediate EBOV internali-
zation, do the different receptors mediate internalization through the same endosomal pathway
and into the same endosomal compartment? For those filoviruses that do not require Cathep-
sin B and L, what endosomal proteases are responsible for their GP processing? What is the
role of NPC1? Does NPC1 binding directly lead to EBOV fusion? If so, why are additional pro-
teolysis events required and what protease(s) in which vesicular compartment mediate this sec-
ond processing step? Finally, in terms of the big picture, what selective advantages are there for
enveloped viruses such as filoviruses to use relatively non-specific, low-affinity mechanisms for
internalization? Certainly, a growing body of evidence suggests that there must be advantages.
These might include a breadth of tropism that would otherwise not be available to enveloped
viruses. Further, using these entry mechanisms protects critical RBD and fusion residues from
neutralizing antibodies by limiting extracellular exposure of these GP elements; in the current
entry model for filoviruses, these sequences are solely exposed late within the endosomal/lyso-
somal compartments. A better understanding of these paradigm-shifting findings could pro-
vide additional drug targets to complement the current repertoire of Ebola virus antivirals in
development. No doubt, the continued pursuit of answers to these questions by a number of
groups will provide significant insights into both EBOV and, more broadly, virus biology.
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